High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 16906034)

Published in Transplantation on August 15, 2006

Authors

Joke I Roodnat1, Eveline A F J van Gurp, Paul G H Mulder, Teun van Gelder, Yolanda B de Rijke, Wouter W de Herder, Judith A Kal-van Gestel, Huib A P Pols, Jan N M Ijzermans, Willem Weimar

Author Affiliations

1: Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands. J.Roodnat@erasmusmc.nl

Articles by these authors

Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol (2008) 7.65

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival. J Clin Oncol (2008) 4.66

Association between blood lactate levels, Sequential Organ Failure Assessment subscores, and 28-day mortality during early and late intensive care unit stay: a retrospective observational study. Crit Care Med (2009) 3.83

Effects of perinatal exposure to PCBs and dioxins on play behavior in Dutch children at school age. Environ Health Perspect (2002) 3.36

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol (2009) 3.05

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas (2010) 3.00

Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma. Neuroendocrinology (2007) 2.95

Renal extraction of cystatin C vs 125I-iothalamate in hypertensive patients. Nephrol Dial Transplant (2006) 2.72

Serum lipids and disease severity in children with severe meningococcal sepsis. Crit Care Med (2005) 2.46

Oral lichen planus and allergy to dental amalgam restorations. Arch Dermatol (2004) 2.38

Comparison of laparoscopic and mini incision open donor nephrectomy: single blind, randomised controlled clinical trial. BMJ (2006) 2.32

Turning off frequently overridden drug alerts: limited opportunities for doing it safely. J Am Med Inform Assoc (2008) 2.31

Severe hyponatremia with high urine sodium and osmolality. Clin Chem (2009) 2.22

Association of gestational maternal hypothyroxinemia and increased autism risk. Ann Neurol (2013) 2.21

Effects of prenatal PCB and dioxin background exposure on cognitive and motor abilities in Dutch children at school age. J Pediatr (2002) 2.18

Protection against renal ischemia-reperfusion injury by ischemic postconditioning. Transplantation (2013) 2.17

Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. Neuroendocrinology (2004) 2.16

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. Acta Oncol (2006) 2.16

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus. Clin Pharmacol Ther (2003) 2.09

Drug safety alert generation and overriding in a large Dutch university medical centre. Pharmacoepidemiol Drug Saf (2009) 2.08

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors. J Clin Oncol (2005) 2.07

Cost effectiveness of laparoscopic versus mini-incision open donor nephrectomy: a randomized study. Transplantation (2007) 2.05

Can we turn down autonomous wishes to donate anonymously? Transpl Int (2011) 2.03

Incidence of sexually transmitted diseases and HIV infection related to perceived HIV/AIDS threat since highly active antiretroviral therapy availability in men who have sex with men. Sex Transm Dis (2005) 2.03

Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study. J Clin Endocrinol Metab (2010) 1.93

Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol (2010) 1.91

Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab (2003) 1.86

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology (2012) 1.86

Heritability of blood pressure traits and the genetic contribution to blood pressure variance explained by four blood-pressure-related genes. J Hypertens (2007) 1.85

A genome-wide association study of acenocoumarol maintenance dosage. Hum Mol Genet (2009) 1.78

Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up. Transplantation (2011) 1.77

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors. Endocr Relat Cancer (2010) 1.76

Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study. Endocr Relat Cancer (2012) 1.76

Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics (2004) 1.73

End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells. Nephrol Dial Transplant (2009) 1.71

Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin. Transplantation (2008) 1.70

Donor nephrectomy: mini-incision muscle-splitting open approach versus laparoscopy. Transplantation (2006) 1.69

Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol (2013) 1.68

Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med (2003) 1.68

Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome. Ann Neurol (2009) 1.67

A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients. Clin Chem (2011) 1.64

Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy? Ann Surg Oncol (2011) 1.63

Renal function and size at young adult age after intrauterine growth restriction and very premature birth. Am J Kidney Dis (2007) 1.61

Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the Generation R Study. Thyroid (2011) 1.61

Preoperative fasting protects mice against hepatic ischemia/reperfusion injury: mechanisms and effects on liver regeneration. Liver Transpl (2011) 1.59

Glucose supplementation does not interfere with fasting-induced protection against renal ischemia/reperfusion injury in mice. Transplantation (2011) 1.57

Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (2013) 1.57

ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption. Transpl Int (2014) 1.53

Organ donations and unused potential donations in traumatic brain injury, subarachnoid haemorrhage and intracerebral haemorrhage. Intensive Care Med (2006) 1.53

Postmortal or living related donor: preferences of kidney patients. Transpl Int (2005) 1.53

Avoiding the issue: patients' (non)communication with potential living kidney donors. Patient Educ Couns (2008) 1.52

Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. Transplantation (2005) 1.51

Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature (2005) 1.51

Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. Am J Transplant (2005) 1.50

Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study. Br J Clin Pharmacol (2006) 1.48

Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol (2007) 1.48

A psychometric analysis of the Rotterdam Renal Replacement Knowledge-Test (R3K-T) using item response theory. Transpl Int (2013) 1.48

Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Transm Dis (2003) 1.47

Dealing With Public Solicitation of Organs From Living Donors-An ELPAT View. Transplantation (2015) 1.47

Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation. Transplantation (2011) 1.46

The use of serological titres of IgA and IgG in (early) discrimination between rectal infection with non-lymphogranuloma venereum and lymphogranuloma venereum serovars of Chlamydia trachomatis. Sex Transm Infect (2007) 1.46

Altruistic living kidney donation challenges psychosocial research and policy: a response to previous articles. Transplantation (2005) 1.44

Living kidney donors and hypoxia-inducible factor-1alpha. Transplantation (2003) 1.44

Incidence and risk factors of disability in the elderly: the Rotterdam Study. Prev Med (2006) 1.43

SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J Clin Endocrinol Metab (2011) 1.42

The β-human chorionic gonadotropin-related peptide LQGV reduces mortality and inflammation in a murine polymicrobial sepsis model. Crit Care Med (2011) 1.42

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology (2012) 1.41

A High Comorbidity Score Should Not be a Contraindication for Kidney Transplantation. Transplantation (2016) 1.41

High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation. Nephrol Dial Transplant (2010) 1.40

Soluble Flt1 and placental growth factor are novel determinants of newborn thyroid (dys)function: the generation R study. J Clin Endocrinol Metab (2014) 1.40

Risk factors associated with encapsulating peritoneal sclerosis in Dutch EPS study. Perit Dial Int (2011) 1.40

Deficient TNF-alpha and IFN-gamma production correlates with nondetectable donor-specific cytotoxicity after clinical kidney transplantation. Transplantation (2009) 1.38

Tactile guidance of prey capture in Etruscan shrews. Proc Natl Acad Sci U S A (2006) 1.37

The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users. Breast Cancer Res Treat (2009) 1.34

Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer. Hepatology (2012) 1.33

Strategies for discontinuing long-term benzodiazepine use: meta-analysis. Br J Psychiatry (2006) 1.33

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease. N Engl J Med (2010) 1.32

Fundamental role for HO-1 in the self-protection of renal allografts. Am J Transplant (2004) 1.30

Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. Nephrol Dial Transplant (2010) 1.29

Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology (2011) 1.29

Long-term follow-up of endothelial cell change after Artisan phakic intraocular lens implantation. Ophthalmology (2007) 1.28

EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging (2012) 1.28

Starting a crossover kidney transplantation program in the Netherlands: ethical and psychological considerations. Transplantation (2004) 1.27

Maternal thyroid function during pregnancy and behavioral problems in the offspring: the generation R study. Pediatr Res (2011) 1.27

Paraneoplastic syndromes secondary to neuroendocrine tumours. Endocr Relat Cancer (2010) 1.26

Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study. Am J Transplant (2004) 1.26

Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients. J Am Soc Nephrol (2006) 1.24

Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors. Semin Nucl Med (2010) 1.23

Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate. Eur J Nucl Med Mol Imaging (2009) 1.23